Sana Biotechnology Inc (SANA)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $605.26M
Last updated: Nov 17, 2026 at 11:06 AM ET
Sana Biotechnology Inc (SANA) Earnings: Report Dates and Results
Sana Biotechnology (SANA) is expected to report earnings on Mar 1, 2027. In the quarter ended Sep 30, 2026, Sana Biotechnology reported EPS of -$0.14, above the -$0.18 estimate. It beat the EPS estimate in 6 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
SANA has an expected report date of Mar 1, 2027.
Earnings History
Of the 24 quarters below that had an estimate, SANA beat 11, missed 11 and matched 2. The widest gap in the table came in the quarter ended Dec 31, 2020, when EPS landed 626.83% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported |
|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.14 | -$0.18 | -$0.19 - -$0.10 | +22.22% | Beat | N/A | 4 | 2 up, 1 down | Nov 5, 2026 |
| Jun 30, 2026 | -$0.13 | -$0.15 | N/A | +13.33% | Beat | N/A | 4 | 0 up, 0 down | Aug 11, 2026 |
| Mar 31, 2026 | -$0.14 | -$0.15 | -$0.20 - -$0.10 | +6.67% | Beat | N/A | 3 | 0 up, 0 down | May 11, 2026 |
| Dec 31, 2025 | -$0.16 | -$0.14 | -$0.18 - -$0.10 | -10.80% | Miss | N/A | 4 | 0 up, 1 down | Mar 3, 2026 |
| Sep 30, 2025 | -$0.15 | -$0.19 | -$0.21 - -$0.15 | +21.05% | Beat | N/A | 4 | 1 up, 0 down | Nov 6, 2025 |
| Jun 30, 2025 | -$0.16 | -$0.21 | -$0.24 - -$0.20 | +23.81% | Beat | N/A | 3 | 0 up, 0 down | Aug 11, 2025 |
| Mar 31, 2025 | -$0.20 | -$0.20 | -$0.20 - -$0.20 | 0.00% | In line | N/A | 1 | 0 up, 0 down | May 8, 2025 |
| Dec 31, 2024 | -$0.23 | -$0.24 | -$0.31 - -$0.20 | +5.27% | Beat | N/A | 3 | 0 up, 0 down | Mar 17, 2025 |
| Sep 30, 2024 | -$0.27 | -$0.27 | -$0.27 - -$0.22 | 0.00% | In line | N/A | 6 | 2 up, 0 down | Nov 8, 2024 |
| Jun 30, 2024 | -$0.32 | -$0.24 | N/A | -33.33% | Miss | N/A | 4 | 0 up, 0 down | Aug 8, 2024 |
| Mar 31, 2024 | -$0.32 | -$0.22 | N/A | -45.45% | Miss | N/A | 5 | 1 up, 0 down | May 8, 2024 |
| Dec 31, 2023 | -$0.41 | -$0.38 | -$0.42 - -$0.33 | -7.89% | Miss | N/A | 6 | 0 up, 0 down | Feb 29, 2024 |
| Sep 30, 2023 | -$0.41 | -$0.45 | -$0.50 - -$0.38 | +8.89% | Beat | N/A | 6 | 0 up, 0 down | Nov 8, 2023 |
| Jun 30, 2023 | -$0.59 | -$0.43 | -$0.45 - -$0.40 | -37.21% | Miss | N/A | 3 | 0 up, 0 down | Aug 3, 2023 |
| Mar 31, 2023 | -$0.43 | -$0.37 | -$0.60 - -$0.35 | -16.22% | Miss | N/A | 3 | 1 up, 0 down | May 8, 2023 |
| Dec 31, 2022 | -$0.38 | -$0.51 | -$0.52 - -$0.51 | +25.49% | Beat | N/A | 2 | 0 up, 0 down | Mar 16, 2023 |
| Sep 30, 2022 | -$0.48 | -$0.39 | N/A | -23.08% | Miss | N/A | 2 | 0 up, 0 down | Nov 2, 2022 |
| Jun 30, 2022 | -$0.47 | -$0.46 | N/A | -2.17% | Miss | N/A | N/A | 0 up, 0 down | Aug 4, 2022 |
| Mar 31, 2022 | -$0.47 | -$0.38 | -$0.55 - -$0.38 | -23.68% | Miss | N/A | 3 | 0 up, 0 down | May 10, 2022 |
| Dec 31, 2021 | -$0.60 | -$0.56 | -$0.72 - -$0.39 | -7.14% | Miss | N/A | 2 | N/A | Mar 16, 2022 |
| Sep 30, 2021 | -$0.37 | -$0.50 | -$0.71 - -$0.29 | +26.00% | Beat | N/A | 3 | N/A | Nov 8, 2021 |
| Jun 30, 2021 | -$0.32 | -$0.45 | -$0.62 - -$0.28 | +28.89% | Beat | N/A | 2 | N/A | Aug 4, 2021 |
| Mar 31, 2021 | -$0.29 | -$0.58 | -$1.05 - -$0.29 | +50.00% | Beat | N/A | 3 | N/A | May 5, 2021 |
| Dec 31, 2020 | -$2.98 | -$0.41 | -$0.48 - -$0.34 | -626.83% | Miss | N/A | 2 | N/A | Feb 5, 2021 |
| Sep 30, 2019 | -$4.92 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Dec 31, 2019 |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$0.67, after -$1.14 the year before. It was -$7.90 for the year ended Dec 31, 2020, the oldest of the 6 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$0.67 | N/A |
| Dec 31, 2024 | -$1.14 | N/A |
| Dec 31, 2023 | -$1.84 | N/A |
| Dec 31, 2022 | -$1.80 | N/A |
| Dec 31, 2021 | -$1.58 | N/A |
| Dec 31, 2020 | -$7.90 | N/A |
Frequently Asked Questions About SANA
When is Sana Biotechnology's next earnings date?
Sana Biotechnology's next earnings report is expected for Mar 1, 2027.
Did SANA beat earnings estimates last quarter?
Yes. Sana Biotechnology reported EPS of -$0.14 for the quarter ended Sep 30, 2026, above the -$0.18 estimate, a 22.22% surprise.
What EPS do analysts expect from SANA next quarter?
The consensus EPS estimate for Sana Biotechnology for the quarter ending Dec 31, 2026 is -$0.18 from 12 analysts, with estimates from -$0.26 to -$0.09.
How often does SANA beat earnings estimates?
Sana Biotechnology beat the EPS estimate in 6 of the last 8 quarters, with an average surprise of +10.19%.
SANA pages: Overview, Earnings, Forecast, Financials, Competitors